--> -->

​Ossiform raises new capital

Ossiform raises capital through West Hill

ODENSE, October 5th, 2022 – Ossiform, We Print Bone™, is pleased to announce that it has completed a £6 million capital raise through West Hill Capital. Ossiform has developed a disruptive and patented technology to produce and supply P3D Bone; 3D printed patient-specific, resorbable bone implants that remodel into real living bone. Positive testing results toward FDA clearance have been obtained, and sales of Ossiform’s 3D printed R&D products for enhancing bone and cancer research, the P3D Scaffolds, have been established internationally.

The raised capital will be used to get the P3D Bone to market and reach its first clinical use in the USA in 2023, and to establish the production line for the fully patient specific P3D Bone.

“We are very pleased to collaborate with West Hill raising the capital needed to expand our activities and prepare our P3D Bone for the US$3.8 billion bone implant market, and despite the current crises we succeeded.”, says Thea Wulff Olesen, CEO of Ossiform.

Robert Caie, Managing Partner at West Hill Capital, added, “West Hill is once again delighted to be supporting Ossiform in the next stage of the Company’s development. This fascinating technology has the potential to transform how millions of patients receive implants every year by eliminating complications, reducing the cost of treatment, and dramatically improving functional and aesthetic outcomes.”​

Ossiform

Ossiform is dedicated to improving the lives of people with bone defects. We provide patient specific, natural, and resorbable bone implants to reduce complications, improve functional and aesthetic outcomes and obtain faster recovery. We are continuously working to redefine bone replacements through progressive research and close collaboration with physicians. Our patient-centric approach and commitment to innovation, quality, and progress steer our efforts to provide best-in-class implant solutions that facilitate the natural forming of new bone.

For more information, please contact:

Ossiform:

Thea Wulff Olesen, CEO

two@ossiform.com

Tel.: +45 26 32 63 32

West Hill Capital:

 Robert Caie, Managing Partner

rfcaie@westhillcapital.co.uk

 Tel: +44 20 34 40 75 56

Our mission is your benefits

Our mission is to provide 3D printed natural bone implants to reduce complication, improve functional & aesthetics outcomes, and obtain faster recovery

Natural bone porosity, optimized for bone regeneration

The unique structure of the P3D Bone is designed to facilitate the natural forming of new bone.

Remodels into real living bone

The natural material and structure ensure effective remodeling of the implant into new vascularized bone.

Patient specific - designed with the patient's uniqueness in mind

The P3D Bone is 3D printed to enable a full restoration of the functionality and appearance of bones. ​

Resorbable material with structural support

P3D Bone eliminates the need to harvest bone as well as the need for permanent and ill-fitting implants.

P3D Bone Void Filler is expected to launch in 2023

Our first 3D printed, resorbable P3D Bone with modifiable dimensions and a lifelike bone architecture.

P3D Bone Patient Specific Implant is expected to launch in 2024

Our patient specific and resorbable P3D Bone based on the patient's own CT/MRI scan data. ​

We Print Bone​™

Contact us here

Contact us for questions, general inquiries, or to request a quote.
We strive to provide you with highest quality service and expertise in medical 3D printing.

 
 
 
Please make sure all required fields are filled out correctly

Do you have questions?

Give us a call or write to us by email: info@ossiform.com

We will get back to you as soon as possible.​

logo - hvid u. baggrund

Ossiform ApS - We Print Bone™

​Oslogade 1, 5000 Odense C​, Denmark

CVR. 38838512

facebook  linkedin  twitter  instagram